Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yixuan Zhang
Observed name:
Y.Y. Zhang
Institution:
The Hong Kong University of Science and Technology (Guangzhou)
Observed institutions:
Chinese University of Hong Kong,
The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital),
The Hong Kong University of Science and Technology (Guangzhou)
ORCID:
0009-0001-3446-3711
Observed ORCIDs:
0009-0001-3446-3711,
0009-0006-0693-5271
OpenAlex ID:
A5079382715
Spin-selective heterogeneous chiral perovskites for circular-polarization-resolved retinomorphic sensors
2026
·
De Yu
, Xin Zhang
, et al.
·
Nature Communications
·
9
PDF
FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
·
Cancer Research
·
8
PD-L1+ neutrophils mediate immune regulation of CD8+ T cells in halo nevi
2025
·
Yixuan Zhang
, Yingying Xu
, et al.
·
Frontiers in Immunology
·
7
Data from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
·
1
SUN-037 Macrophage-specific RNA-sequencing reveals a novel pathogenic mechanism for malignancy-associated acute kidney injury at single-cell resolution
2020
·
J.Y.F. Chung
, P.C.T. Tang
, et al.
·
Kidney International Reports
·
1
Figure S12 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S1 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S2 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S11 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S10 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S7 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S14 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S4 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S9 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S13 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S8 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S6 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S3 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Figure S5 from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Supplementary Tables from FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors
2025
·
Jiahuan Lu
, Thomas Ting-Hei Chan
, et al.
Show more works
View as search
Works count:
20
Citation count:
26
H-index:
3
I10-index:
Year
Topic
Type